UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice

Blood, 2008-04, Vol.111 (8), p.3931-3940

2008

Volltextzugriff (PDF)

Anagrelide Treatment in Early Pregnancy in a Patient with JAK2V617F-Positive Essential Thrombocythemia: Case Report and Literature Review

Acta haematologica, 2009-01, Vol.122 (4), p.221-222

2009

Volltextzugriff (PDF)

Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice. Commentary

Blood, 2008, Vol.111 (8)

2008

Volltextzugriff (PDF)

Ratio of Mutant JAK2-V617F to Wild Type Jak2 Determines the MPD Phenotypes in Transgenic Mice

Blood, 2007-11, Vol.110 (11), p.674-674

2007

Volltextzugriff (PDF)

Nowe czynniki prognostyczne w pierwotnym włóknieniu szpiku — aktualny stan wiedzy

Hematologia (Gdańsk), 2018-02, Vol.8 (4), p.271-279

2018

Volltextzugriff (PDF)

Screening of JAK2 V617F Mutation in 84 Patients with Thrombocythemia and Erythrocytosis. Is Necesary for Diagnosis of a Chronic Myeloproliferative Disorders?

Blood, 2006-11, Vol.108 (11), p.4891-4891

2006

Volltextzugriff (PDF)

Myeloproliferative neoplasms: young patients, current data and future considerations

Annals of hematology, 2024-09, Vol.103 (9), p.3287-3291

2024

Volltextzugriff (PDF)

Profound Nanoscale Structural and Biomechanical Changes in DNA Helix upon Treatment with Anthracycline Drugs

International journal of molecular sciences, 2020-06, Vol.21 (11), p.4142

2020

Volltextzugriff (PDF)

Primary Immune Thrombocytopenia and Essential Thrombocythemia: So Different and yet Somehow Similar-Cases Series and a Review of the Literature

International journal of molecular sciences, 2021-10, Vol.22 (20), p.10918

2021

Volltextzugriff (PDF)

Inflammation-related molecules in tears of patients with chronic ocular pain and dry eye disease

Experimental eye research, 2022-06, Vol.219, p.109057-109057, Article 109057

2022

Volltextzugriff (PDF)

Impact of pacritinib on symptoms in with thrombocytopenia and myelofibrosis who require red blood cell transfusion

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.6577-6577

2024

Volltextzugriff (PDF)

Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study

Leukemia, 2020-09, Vol.34 (9), p.2333-2341

2020

Volltextzugriff (PDF)

Low Bone Mineral Content: A New Risk Factor for Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Blood, 2023-11, Vol.142 (Supplement 1), p.2149-2149

2023

Volltextzugriff (PDF)

High molecular risk variants, severe thrombocytopenia and large unstained cells count affect the outcome in primary myelofibrosis

Journal of applied genetics, 2023-09, Vol.64 (3), p.479-491

2023

Volltextzugriff (PDF)

Creutzfeldt-Jakob Disease as a Reason for Neurological Deterioration in a Patient with Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Turkish journal of haematology, 2023-05, Vol.40 (2), p.132-134

2023

Volltextzugriff (PDF)

Impact of Pacritinib on Symptoms in Thrombocytopenic Myelofibrosis Patients Who Require Red Blood Cell Transfusion

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S205-S205

2024

Volltextzugriff (PDF)

MPN-497 Impact of Pacritinib on Symptoms in Thrombocytopenic Myelofibrosis Patients Who Require Red Blood Cell Transfusion

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S436-S436

2024

Volltextzugriff (PDF)

Advances in decision support for diagnosis and early management of acute leukaemia

The Lancet. Digital health, 2024-05, Vol.6 (5), p.e300-e301

2024

Volltextzugriff (PDF)

A hybrid protocol CLAG-M, a possible player for the first-line therapy of patients with mixed phenotype acute leukemia. A Polish Adult Leukemia Group experience

Frontiers in oncology, 2024-05, Vol.14, p.1395992-1395992

2024

Volltextzugriff (PDF)

POSTER: MPN-339 Outcomes of Patients With Myelofibrosis and Elevated Peripheral Blood Blasts Treated With Pacritinib on Phase II/III Trials

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S193-S193

2023

Volltextzugriff (PDF)

MPN-339 Outcomes of Patients With Myelofibrosis and Elevated Peripheral Blood Blasts Treated With Pacritinib on Phase II/III Trials

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S389-S390

2023

Volltextzugriff (PDF)

A Phase 1 Dose-Escalation Study of the Cladribine Added to CPX-351 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) a Study of the Polish Adult Leukemia Group (AML-1/2018): Preliminary Results of the Dose Escalation Stage

Blood, 2022-11, Vol.140 (Supplement 1), p.6165-6166

2022

Volltextzugriff (PDF)

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as novel prognostic biomarkers in BCR-ABL negative myeloproliferative neoplasms

Annals of hematology, 2024-09

2024

Volltextzugriff (PDF)

A Phase 1 Dose-Escalation Study of the Cladribine Added to CPX-351 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) - the Polish Adult Leukemia Group AML-1/2018 Study

Blood, 2023-11, Vol.142 (Supplement 1), p.5914-5914

2023

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(98)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(36)
Clinical Lymphoma, Myeloma And Leukemia
(9)
Hematologia
(5)
Leukemia
(5)
Leukemia & Lymphoma
(5)
Annals Of Hematology
(4)
Hemasphere
(3)
Acta Haematologica Polonica
(2)
Blood Cancer Journal
(2)
Cancers
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice

Anagrelide Treatment in Early Pregnancy in a Patient with JAK2V617F-Positive Essential Thrombocythemia: Case Report and Literature Review

Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice. Commentary

Ratio of Mutant JAK2-V617F to Wild Type Jak2 Determines the MPD Phenotypes in Transgenic Mice

Nowe czynniki prognostyczne w pierwotnym włóknieniu szpiku — aktualny stan wiedzy

Screening of JAK2 V617F Mutation in 84 Patients with Thrombocythemia and Erythrocytosis. Is Necesary for Diagnosis of a Chronic Myeloproliferative Disorders?

Myeloproliferative neoplasms: young patients, current data and future considerations

Profound Nanoscale Structural and Biomechanical Changes in DNA Helix upon Treatment with Anthracycline Drugs

Primary Immune Thrombocytopenia and Essential Thrombocythemia: So Different and yet Somehow Similar-Cases Series and a Review of the Literature

Inflammation-related molecules in tears of patients with chronic ocular pain and dry eye disease

Impact of pacritinib on symptoms in with thrombocytopenia and myelofibrosis who require red blood cell transfusion

Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study

Low Bone Mineral Content: A New Risk Factor for Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

High molecular risk variants, severe thrombocytopenia and large unstained cells count affect the outcome in primary myelofibrosis

Creutzfeldt-Jakob Disease as a Reason for Neurological Deterioration in a Patient with Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Impact of Pacritinib on Symptoms in Thrombocytopenic Myelofibrosis Patients Who Require Red Blood Cell Transfusion

MPN-497 Impact of Pacritinib on Symptoms in Thrombocytopenic Myelofibrosis Patients Who Require Red Blood Cell Transfusion

Advances in decision support for diagnosis and early management of acute leukaemia

A hybrid protocol CLAG-M, a possible player for the first-line therapy of patients with mixed phenotype acute leukemia. A Polish Adult Leukemia Group experience

Publisher Correction: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study

POSTER: MPN-339 Outcomes of Patients With Myelofibrosis and Elevated Peripheral Blood Blasts Treated With Pacritinib on Phase II/III Trials

MPN-339 Outcomes of Patients With Myelofibrosis and Elevated Peripheral Blood Blasts Treated With Pacritinib on Phase II/III Trials

A Phase 1 Dose-Escalation Study of the Cladribine Added to CPX-351 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) a Study of the Polish Adult Leukemia Group (AML-1/2018): Preliminary Results of the Dose Escalation Stage

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as novel prognostic biomarkers in BCR-ABL negative myeloproliferative neoplasms

A Phase 1 Dose-Escalation Study of the Cladribine Added to CPX-351 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) - the Polish Adult Leukemia Group AML-1/2018 Study

Suchergebnisse filtern